tradingkey.logo

BRIEF-Expert Systems and Traws Pharma Report Breakthrough in H5N1Bird Flu Antiviral Program

ReutersJan 10, 2025 11:17 PM

- Traws Pharma Inc TRAW.O:

  • EXPERT SYSTEMS: ANNOUNCED A SIGNIFICANT MILESTONE IN A DEVELOPMENT OF TRAWS PHARMA'S H5N1 ANTIVIRAL PROGRAM

  • EXPERT SYSTEMS: WITH COMPLETION OF PHASE 1 TRIALS, PLANS ARE UNDERWAY TO INITIATE PHASE 2 EFFICACY STUDIES IN FIRST HALF OF 2025

Source text: ID:nPn6sWG9ma

Further company coverage: TRAW.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: For information purposes only. Past performance is not indicative of future results.

Related Articles